Aditxt

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aditxt and other ETFs, options, and stocks.

About ADTX

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore.

CEO

Amro Albanna

CEOAmro Albanna

Employees

Employees26

Headquarters

Mountain View, California

HeadquartersMountain View, California

Founded

2017

Founded2017

Employees

Employees26

ADTX Key Statistics

Market cap

290.63K

Market cap290.63K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

45.64M

Average volume45.64M

High today

$0.0891

High today$0.0891

Low today

$0.049

Low today$0.049

Open price

$0.0679

Open price$0.0679

Volume

63.04M

Volume63.04M

52 Week high

$139.95

52 Week high$139.95

52 Week low

$0.049

52 Week low$0.049

ADTX News

TipRanks 1d

Aditxt Executes Reverse Stock Split to Meet Nasdaq Rules

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 5d

Aditxt begins enrollment in Mitomic Endometriosis Test study

Aditxt (ADTX) announced that its subsidiary, Pearsanta, has begun enrollment in their prospective clinical study evaluating the Mitomic Endometriosis Test, a no...

People also own

Based on the portfolios of people who own ADTX. This list is generated using Robinhood data, and it’s not a recommendation.